Trump’s Drug Price Comments Weigh on Biotech and Pharma ETFs and Shares
Trump told Time that he wants to lower drug prices, a move that has hit the drug and biotech segments due to his comments.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 184
Repros Therapeutics Drops on FDA Vote
Repros Therapeutics saw its shares take a loss on Wednesday after the company provided a key FDA update.
Teva Shares Slide on Management Change
Teva Pharmaceutical Industries shares sank on Tuesday after the company announced the appointment of Dipankar Bhattacharjee as chief executive for its global generic medicines group.
10 Major Pharma and FDA Catalysts Coming in December
24/7 Wall St. has collected several catalysts that are coming up on the calendar in the month of December.
EyeGate Pharmaceuticals Continues to Win in Mid-Stage Trial
EyeGate Pharmaceuticals shares rose about 10% on Monday after the company announced promising data from its mid-stage trial of its leading product candidate.
NeuroDerm Jumps on Critical FDA Update
NeuroDerm has announced that it intends to pursue a comparative bioavailability regulatory path for the its lead product candidate ND0612 based on comparative pharmacokinetic data in place of data from Phase 3 clinical efficacy…
GW Pharmaceuticals Shows Smaller Than Expected Q4 Loss
GW Pharmaceuticals reported its fiscal fourth-quarter financial results before the markets opened on Monday.
Cempra Rises on Late-Stage Trial
Shares of Cempra saw a handy gain early Monday after Toyama Chemical announced that it had begun Phase 3 clinical trials with solithromycin in Japan for patients with respiratory infections.
4 Merrill Lynch Med Tech and Drug Dividend Stocks to Buy With Huge 2017 Potential
These are stocks that make good sense for investors looking to add to their overall equity holdings. They are all trading well below their 52-week highs and should be attracting substantial institutional interest in…
Health Care Spending Reaches $3.2 Trillion, Nearly $10,000 per Person
Health care costs are on a rapid upturn, and with a vengeance, reaching $3.2 trillion in 2015. Affordability is at the core of the national debate on health care funding.
Envision Healthcare Triples on Completed Merger
These health care companies are looking to form one of the nation’s largest provider organizations in an effort to help shape the future of health care delivery.
Analyst’s Top Pharmaceutical Buys Offer Big Dividends and Growth Potential
With the top pharmaceutical stocks trailing the market by a large margin, they are starting to look very attractive for long-term growth and income investors.
FDA Requests Additional Data on Amicus’ Fabry Disease Treatment
Amicus Therapeutics, Inc. (NASDAQ: FOLD) is watching its shares drop on Tuesday after the company provided an update on its regulatory pathway for its Fabry Disease treatment. After the company had several collaborative discussions…
Nivalis Therapeutics Crumbles on Failed Mid-Stage Trial
Nivalis Therapeutics, Inc. (NASDAQ: NVLS) is watching its shares crumble on Tuesday after the company gave an update on its mid-stage Cystic Fibrosis (CF) trial. Specifically, the company announced topline results from the its…
Genetic Technologies Practically Doubles on Licensing Agreement
Shares of Genetic Technologies practically doubled in Tuesday's session after the company announced the signing of an exclusive worldwide license agreement with the University of Melbourne.